FDA delays AstraZeneca decision on camizestrant as regulators seek more data
FDA greenlights AstraZeneca’s Imfinzi combo in bladder cancer breakthrough
AstraZeneca reports mixed Phase III results for anselamimab in rare cardiac amyloidosis trial
Glenmark posts strong FY26 results with 27.5% revenue jump
Merck’s experimental cancer drug wins FDA breakthrough status in key lung cancer setting
Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial
AbbVie wins FDA nod for DECNUPAZ in rare blood cancer
Eli Lilly secures full PBM coverage for obesity drug portfolio expanding access to millions
Solvay and Pantys deepen partnership to expand menstrual health access
India’s MedTech industry is entering its defining decade: Dr. Shravan Subramanyam, MD, BPL Medical Technologies
Crucially, Lupin is the exclusive first-to-file applicant for this product and is eligible for 180-day generic drug exclusivity in the U.S. market
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1780127245)
